![](/img/cover-not-exists.png)
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study
Infante, Jeffrey R., Reid, Tony R., Cohn, Allen L., Edenfield, William J., Cescon, Terrence P., Hamm, John T., Malik, Imtiaz A., Rado, Thomas A., McGee, Philip J., Richards, Donald A., Tarazi, Jamal,Volume:
119
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.28112
Date:
July, 2013
File:
PDF, 330 KB
english, 2013